Evidence map›Paper›PMID 40822493›Full record

ArticleFrontiers in pharmacology2025

Kuikui Chen, Jie Liang, Yong Tan, Yaohua Li, Xiaojiao Pan, Zhonghui Guo, Wentao Zhang, Zongxi Sun

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kuikui ChenSchool of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Jie LiangSchool of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Yong TanSchool of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Yaohua LiTeaching Experiment Training Center, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Xiaojiao PanSchool of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Zhonghui GuoSchool of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Wentao ZhangTeaching Experiment Training Center, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Zongxi SunRuikang Clinical Medical School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: The metabolites of Results: Thirty-two metabolites were identified in ILW. Among them, the concentrations of caffeic acid, rosmarinic acid, schaftoside, and isoschaftoside were determined to be 1.10, 5.13, 0.12, and 0.18 mg·g Conclusion: ILW exerts protective effects against liver fibrosis by attenuating inflammation, fibrosis, and liver damage through modulation metabolism modulation and NF-κB pathway inhibition. These findings provide a scientific basis for the traditional use of

Indexed as

Isodon lophanthoidesliver fibrosismetabolomicsmulti-omicsqualitative and quantitative analysis

Identifiers

PMID40822493
PMCPMC12354614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.